Lefevre, P A <br/><br/>
Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol.  [electronic resource] 

 -  Mutagenesis  Jan 1997 
 - 45-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0267-8357 
<br/><br/><label>Standard No.: </label>10.1093/mutage/12.1.45  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Genetically Modified<br/>Bacterial Proteins--drug effects<br/>Benzothiazoles<br/>Carcinogens--toxicity<br/>Diet<br/>Escherichia coli Proteins<br/>Lac Repressors<br/>Liver--drug effects<br/>Male<br/>Mutagenesis<br/>Mutagenicity Tests<br/>Mutation<br/>Rats<br/>Rats, Inbred F344<br/>Repressor Proteins--drug effects<br/>Riboflavin--pharmacology<br/>Sensitivity and Specificity<br/>Thiazoles--toxicity<br/>Transgenes<br/>p-Dimethylaminoazobenzene--analogs & derivatives